We found that, the CRISPR/Cas9 knockout CCR5 cells protected against cell death only the R5-tropic HIV-1BaL infections at both low and high levels of viral infection but did not protect from the X4-tropic HIV-1NL4-3. The gene discussed is CCR5; the disease is viral infectious disease.